Quick Links

Douglas Institute news

A tiny molecule may help battle depression

By Cynthia Lee - News - June 8, 2014 Levels of a small molecule found only in humans and in other primates are lower in the brains of depressed individuals, according to researchers at McGill University and the Douglas Institute. This discovery may hold a key to improving treatment options for those who suffer from depression.

Category :
Published on : 08 Jun 2014

9,8 millions de dollars pour créer un centre spécialisé en recherche sur la dépression et le suicide

Montréal, 4 février 2014 – Le ministre de la Santé et des Services sociaux (MSSS) Réjean Hébert, M.D., Ph.D., accompagné de la directrice générale de l’Institut universitaire en santé mentale Douglas, madame Lynne McVey et le chef du programme des troubles dépressifs de l’Institut et directeur du Groupe McGill d’études sur le suicide, Gustavo Turecki, M.D., Ph.D., ont annoncé l’octroi de 7,2 M$ pour la création du

Published on : 06 Feb 2014

Two Douglas psychiatrists honoured by the Verdun community

Mimi Israël, MD, and Serge Beaulieu, MD, PhD received a 2013 “Coup de chapeau verdunois” for their commitment as first-line psychiatrists. The awards were handed out by Roger Cadieux, President of the Forum économique de Verdun, during a recognition ceremony on the evening of November 27. This award recognizes the involvement of Verdun residents and employees.

Published on : 27 Nov 2013

Douglas-Based Research Team Obtains $1.5 Million to Study a New Method of Neuronal Communication

Salah El Mestikawy, PhD, a researcher at The Douglas Institute, along with his research team, have received $1.5 million to explore the dual signalling capacity of neurons. This research grant is one of five new Multi-Investigator Research Initiative (MIRI) grants awarded by Brain Canada with funds from the Canada Brain Research Fund and Partners.

Published on : 27 Nov 2013